Clinical Trials
3 trialsNCT01209195 2016-09-08
A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
Merrimack Pharmaceuticals
Phase 1 Completed
NCT01151046 2016-05-12
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Merrimack Pharmaceuticals
Phase 2 Completed
NCT01421472 2016-05-03
A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
Merrimack Pharmaceuticals
Phase 2 Completed